Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Use of Teclistamab Outside of Clinical Trials in Latin America: Risk of Infections and Immunoglobulin Replacement

Fernando Vieira Pericole, Edvan Crusoe, Glaciano Ribeiro, Juliana Lima, Erica Lammerhirt Ottoni, Rafael Cunha, Abel Costa, Priscilla Cury, James Maciel, Vania Hungria

Blood (2024) 144 (Supplement 1): 7847.

https://doi.org/10.1182/blood-2024-209492

Published: 2024

Journal Articles

Results of Imatinib Therapy In Patients with Early and Late Chronic-Phase Chronic Myeloid Leukemia In a South Brazilian Cohort.

Marcelo Capra, MD, Mariza Shaan, MD, Katia Fassina, MD, Mario Sérgio Fernandes, MD, Marco Antônio Schilling, MD, Denise Almeida, MD, Moema Nene, MD, Tânia Hellwig, MD, Gilca Nachtigal, MD, Adriana Zardo, MD, Andréia Dias Almeida, MD, Tito Vanelli Costa, MD, Erica Lammerhirt Ottoni, MD, Mayde Seadi Torriani, Christina G S Fraga, MD, Liane Esteves Daudt, MD, PhD, Lucia Silla, MD, PhD, Laura Fogliatto, MD

Blood (2010) 116 (21): 4487.

https://doi.org/10.1182/blood.V116.21.4487.4487

Published: 2010

Journal Articles

Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Low Grade Non Hodgkin's Lymphoma: Preliminary Results at Hospital De Clínicas De Porto Alegre (HCPA), Porto Alegre, RS, Brazil.

Beatriz Stela Gomes de Souza Pitombeira Araujo, MD, Alessandra Aparecida Paz, MD, Clarissa Barros Ferreira, MD, Manoela Santos Boffo, MD, Erica Lammerhirt Ottoni, MD, Gustavo Brandão Fischer, MD, Liane Esteves Daudt, MD, PhD, Lucia Silla, MD, PhD

Blood (2010) 116 (21): 4557.

https://doi.org/10.1182/blood.V116.21.4557.4557

Published: 2010

Journal Articles

Impact of Comorbidity In Event-Free Survival, Toxicity and Adherence to Treatment In Chronic Myeloid Leukemia Patients Treated with Imatinib

Laura Fogliatto, MD, Marcelo Capra, MD, Mariza Schaan, MD, Katia Fassina, MD, Mario Sérgio Fernandes, MD, Marco Antônio Schilling, MD, Denise Almeida, MD, Moema Nene, MD, Tânia Hellwig, MD, Gilca Nachtigal, MD, Adriana Zardo João, MD, Andréia Dias Almeida, MD, Tito Vanelli Costa, MD, Erica Lammerhirt Ottoni, MD, Christina G S Fraga, MD, Liane Esteves Daudt, MD, PhD, Lucia Silla, MD, PhD

Blood (2010) 116 (21): 2296.

https://doi.org/10.1182/blood.V116.21.2296.2296

Published: 2010

Journal Articles

Important Role of Early Therapy and Maintaining Uninterrupted Treatment In the Outcomes of Chronic Myelogenous Leukemia Patients Treated with Imatinib

Erica Lammerhirt Ottoni, MD, Marcelo Capra, MD, Mariza Schaan, MD, Marco Antônio Schilling, MD, Katia Fassina, MD, Mario Sérgio Fernandes, MD, Denise Almeida, MD, Moema Nene, MD, Tânia Hellwig, MD, Tito Vanelli Costa, MD, Adriana Zardo, MD, Andréia Dias Almeida, MD, Gilca Nachtigal, MD, Christina G S Fraga, MD, Liane Esteves Daudt, MD, PhD, Lucia Silla, MD, PhD, Laura Fogliatto, MD

Blood (2010) 116 (21): 2300.

https://doi.org/10.1182/blood.V116.21.2300.2300

Published: 2010

NARROW

Use of Teclistamab Outside of Clinical Trials in Latin America: Risk of Infections and Immunoglobulin Replacement

Results of Imatinib Therapy In Patients with Early and Late Chronic-Phase Chronic Myeloid Leukemia In a South Brazilian Cohort.

Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Low Grade Non Hodgkin's Lymphoma: Preliminary Results at Hospital De Clínicas De Porto Alegre (HCPA), Porto Alegre, RS, Brazil.

Impact of Comorbidity In Event-Free Survival, Toxicity and Adherence to Treatment In Chronic Myeloid Leukemia Patients Treated with Imatinib

Important Role of Early Therapy and Maintaining Uninterrupted Treatment In the Outcomes of Chronic Myelogenous Leukemia Patients Treated with Imatinib

Email alerts

ASH Publications

American Society of Hematology

Use of Teclistamab Outside of Clinical Trials in Latin America: Risk of Infections and Immunoglobulin Replacement

Results of Imatinib Therapy In Patients with Early and Late Chronic-Phase Chronic Myeloid Leukemia In a South Brazilian Cohort.

Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Low Grade Non Hodgkin's Lymphoma: Preliminary Results at Hospital De Clínicas De Porto Alegre (HCPA), Porto Alegre, RS, Brazil.

Impact of Comorbidity In Event-Free Survival, Toxicity and Adherence to Treatment In Chronic Myeloid Leukemia Patients Treated with Imatinib

Important Role of Early Therapy and Maintaining Uninterrupted Treatment In the Outcomes of Chronic Myelogenous Leukemia Patients Treated with Imatinib

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only